Study of Olutasidenib and Temozolomide in HGG

Abroad (travel likely)RecruitingPHASE2

Conditions

High Grade Glioma · Astrocytoma · Astrocytoma, Grade III · Astrocytoma, Grade IV · Diffuse Intrinsic Pontine Glioma · WHO Grade III Glioma · WHO Grade IV Glioma · Metastatic Brain Tumor · Diffuse Midline Glioma, H3 K27M-Mutant · Thalamus Tumor · Spinal Tumor · IDH1 Mutation · IDH1 R132 · IDH1 R132C · IDH1 R132H · IDH1 R132S · IDH1 R132G · IDH1 R132L · Oligodendroglioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Children's Hospital Colorado, Aurora, Colorado, United States
Contact: Study coordinator (Dorris Kathleen, MD) · kathleen.dorris@childrenscolorado.org · 720-777-8314
Children's National Medical Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Eugene M Hwang, MD) · ehwang@childrensnational.org · 202-476-5046
University of Miami Hospital and Clinics, Miami, Florida, United States
Contact: Study coordinator (Bradley Gampel, MD) · BXG461@med.miami.edu · 305-951-4690
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Ashley O Plant, MD) · Aplant@luriechildrens.org · 3122274090
Susan Chi, Boston, Massachusetts, United States
Contact: Study coordinator (Susan Chi, MD) · Susan_chi@dfci.harvard.edu · 617-632-4386
Duke University Health System, Durham, North Carolina, United States
Contact: Study coordinator (Daniel Landi, MD) · daniel.landi@duke.edu · 919-684-5301
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Study coordinator (Peter M de Blank, MD) · Peter.deBlank@cchmc.org · 5135172068
Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Study coordinator (Maryam Fouladi, MD, MSc) · Maryam.fouladi@nationwidechildrens.org · 614-722-5758
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Michael J Fisher, MD) · fisherm@email.chop.edu · 215-590-5188
Texas Children's Hospital, Houston, Texas, United States
Contact: Study coordinator (Patricia Baxter, MD) · pabaxter@txch.org · 832-824-4681
Seattle Children's Hospital, Seattle, Washington, United States
Contact: Study coordinator (Erin Crotty, MD) · erin.crotty@seattlechildrens.org · 206-987-2106
Sydney Children's Hospital, Randwick, New South Wales, Australia
Contact: Study coordinator (David Ziegler, MD BS FRACP) · d.ziegler@unsw.edu.au · 61293821730
Queensland Children's Hospital, South Brisbane, Queensland, Australia
Contact: Study coordinator (Tim Hassall, MD BS FRACP) · tim.hassall@health.qld.gov.au · 61730683593
Perth Children's Hospital, Perth, Western Australia, Australia
Contact: Study coordinator (Nick Gottardo, MB FRACP PhD) · nick.gottardo@health.wa.gov.au · 61864560241
The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada
Contact: Study coordinator (Eric Bouffet, MD, FRCP) · eric.bouffet@sickkids.ca · 4168137457
Montreal Children's Hospital, Montreal, Quebec, Canada
Contact: Study coordinator (Genevieve Legault, MD) · Genevieve.legault4@mcgill.ca · 514-412-4445
Hopp Children's Cancer Center at NCT Heidelberg (KiTZ), Heidelberg, Baden-Wurttemberg, Germany
Contact: Study coordinator (Olaf Witt, MD) · o.witt@kitz-heidelberg.de · 0496221423570
Princess Máxima Center, Utrecht, Netherlands
Contact: Study coordinator (Jasper van der Lugt, MD PhD) · D.G.vanVuurden@prinsesmaximacentrum.nl · 31650006759
Starship Children's Hospital, Auckland, Grafton, New Zealand
Contact: Study coordinator (Sarah Hunter, MB, ChB) · SHunter@adhb.govt.nz · 64 9 367 0000
Great Ormond Street Hospital, London, United Kingdom
Contact: Study coordinator (Darren Hargrave) · darren.hargrave@nhs.net · 2078138525

Study leads

Santosh Valvi, FRACP, MSc
Study Chair
Perth Children's Hospital
Nicholas G Gottardo, MB FRACP PhD
Study Chair
Perth Children's Hospital
Michael J Fisher, MD
Study Chair
Children's Hospital of Philadelphia
Maryam Fouladi, MD
Study Chair
Nationwide Children's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

High Grade Glioma · Diffuse Intrinsic Pontine Glioma · Anaplastic Astrocytoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Washington D.C., United States

Targeted Pediatric High-Grade Glioma Therapy

High Grade Glioma · Diffuse Intrinsic Pontine Glioma · Anaplastic Astrocytoma

Abroad (travel likely)Recruiting

Aurora, United States · Washington D.C., United States

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Glioma · Glioblastoma · Recurrent Glioma

Abroad (travel likely)RecruitingPHASE1

Iowa City, United States

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

Glioblastoma Multiforme of Brain · Glioma · Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Tampa, United States · Chicago, United States